Related Experiment Video

Updated: Jul 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K

Understanding cognitive changes in patients with Parkinson's disease using novel fiber quantification techniques

Anupa A Vijayakumari1, Virendra R Mishra2

  • 1Cleveland Clinic Foundation, Cleveland, OH, USA.

Parkinsonism & Related Disorders
|September 22, 2023
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Fiber Connections of the Supplementary Motor Area Revisited: Methodology of Fiber Dissection, DTI, and Three Dimensional Documentation
16:23

Fiber Connections of the Supplementary Motor Area Revisited: Methodology of Fiber Dissection, DTI, and Three Dimensional Documentation

Published on: May 23, 2017

11.3K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

Related Experiment Videos

Last Updated: Jul 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K
Fiber Connections of the Supplementary Motor Area Revisited: Methodology of Fiber Dissection, DTI, and Three Dimensional Documentation
16:23

Fiber Connections of the Supplementary Motor Area Revisited: Methodology of Fiber Dissection, DTI, and Three Dimensional Documentation

Published on: May 23, 2017

11.3K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

590
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
590
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

292
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
292

Articles linked to this work by shared authors, journal, and citation graph.

Machine Learning-Driven Approach to Identify Freezing of Gait in Individuals with Parkinson Disease Using Conventional Structural MRI and Clinical Measures.

AJNR. American journal of neuroradiology·2026

Exploring regional BOLD fluctuations to understand the pathophysiology of mild cognitive impairments in individuals with Parkinson's disease.

Parkinsonism & related disorders·2026

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Parkinson's disease subtypes and their association with probable rapid eye movement sleep behavior disorder severity: a brainstem tractography and machine learning investigation.

Brain imaging and behavior·2024

Neuroanatomical heterogeneity drives divergent cognitive and motor trajectories in Parkinson's disease subtypes.

Journal of the neurological sciences·2024

Dual-Task Performance and Brain Morphologic Characteristics in Parkinson's Disease.

Neuro-degenerative diseases·2024

Health phenome of Parkinson's patients reveals prominent mood-sleep cluster.

Parkinsonism & related disorders·2026

Frequency and outcome of PEG tube implantations in hospitalized Parkinson's disease patients.

Parkinsonism & related disorders·2026

The acute effects of a single session of intermittent hypoxia on blood biomarker concentrations and sleep parameters in people with Parkinson's disease: A randomized, double-blind, crossover trial.

Parkinsonism & related disorders·2026

A framework for multidisciplinary management of autonomic dysfunction in Parkinson disease.

Parkinsonism & related disorders·2026

MANAGE-PD and clinician recommendations for device-aided therapy in Parkinson's disease: Insights from a Turkish tertiary movement disorders cohort.

Parkinsonism & related disorders·2026

Efficacy of citicoline as an add-on therapy in Parkinson's disease: a randomized, double-blind trial.

Parkinsonism & related disorders·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us